Literature DB >> 27170297

Autoimmune hepatitis following drug-induced liver injury in an elderly patient.

Junichiro Kumagai1, Tatsuo Kanda2, Shin Yasui1, Yuki Haga1, Reina Sasaki1, Masato Nakamura1, Shuang Wu1, Shingo Nakamoto1, Makoto Arai1, Yotaro Iino1, Osamu Yokosuka1.   

Abstract

We describe a case of autoimmune hepatitis (AIH) that may have occurred following drug-induced liver injury with camostat mesilate and/or benzbromarone in an elderly patient. The patient's liver biopsy showed chronic active hepatitis and autoimmune hepatitis. Stopping the use of these drugs did not lead to complete remission, but the use of a low dose of corticosteroids completely cured his liver dysfunction. In the present case, liver dysfunction was caused by an autoimmune mechanism. Special attention should be paid to idiopathic AIH and drug-induced AIH in elderly patients.

Entities:  

Keywords:  Autoimmune hepatitis; Benzarone; Benzbromarone; Camostat mesilate

Mesh：

Substances：

Year:  2016        PMID： 27170297     DOI： 10.1007/s12328-016-0648-5

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN： 1865-7265


  20 in total

1.  Fatal fulminant hepatic failure associated with benzbromarone.

Authors:  H Wagayama; K Shiraki; K Sugimoto; K Fujikawa; A Shimizu; K Takase; T Nakano; Y Tameda
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

2.  Fulminant hepatic failure associated with triazolam.

Authors:  Tatsuo Kanda; Osamu Yokosuka; Keiichi Fujiwara; Hiromitsu Saisho; Hidetoshi Shiga; Shigeto Oda; Keiko Okuda; Yasuhiko Sugawara; Masatoshi Makuuchi; Hiroyuki Hirasawa
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

3.  N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis.

Authors:  Tatsuo Kanda; Osamu Yokosuka; Motohisa Tada; Tomoko Kurihara; Setsuko Yoshida; Yutaka Suzuki; Keiichi Nagao; Hiromitsu Saisho
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

4.  An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.

Authors:  Akiko Hisamochi; Masayoshi Kage; Tatsuya Ide; Teruko Arinaga-Hino; Keisuke Amano; Reiichiro Kuwahara; Kei Ogata; Ichiro Miyajima; Ryukichi Kumashiro; Michio Sata; Takuji Torimura
Journal:  J Gastroenterol       Date:  2015-10-30       Impact factor: 7.527

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

6.  Gout and risk of non-alcoholic fatty liver disease.

Authors:  C-F Kuo; K-H Yu; S-F Luo; C-T Chiu; Y-S Ko; J-S Hwang; W-Y Tseng; H-C Chang; H-W Chen; L-C See
Journal:  Scand J Rheumatol       Date:  2010-06-21       Impact factor: 3.641

7.  Present status of autoimmune hepatitis in Japan: a nationwide survey.

Authors:  Masanori Abe; Toshie Mashiba; Mikio Zeniya; Kazuhide Yamamoto; Morikazu Onji; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2011-05-20       Impact factor: 7.527

Review 8.  Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis.

Authors:  L J Scully; D Clarke; R J Barr
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

9.  Hepatic injury caused by benzbromarone.

Authors:  M M van der Klauw; P M Houtman; B H Stricker; P Spoelstra
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

Review 10.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487
View more
  6 in total

Review 1.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

2.  Adverse Effects of Anti-Covid-19 Drug Candidates and Alcohol on Cellular Stress Responses of Hepatocytes.

Authors:  Atousa Khalatbari; Zahra Aghazadeh; Cheng Ji
Journal:  Hepatol Commun       Date:  2022-01-06

3.  Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events.

Authors:  Tatsuo Kanda; Shin Yasui; Masato Nakamura; Shingo Nakamoto; Koji Takahashi; Shuang Wu; Reina Sasaki; Yuki Haga; Sadahisa Ogasawara; Tomoko Saito; Kazufumi Kobayashi; Soichiro Kiyono; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Hitoshi Maruyama; Mitsuhiko Moriyama; Naoya Kato
Journal:  Oncotarget       Date:  2018-03-23

Review 4.  "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.

Authors:  Marcial Sebode; Lisa Schulz; Ansgar W Lohse
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

5.  Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury.

Authors:  Kangan Tan; Wanna Yang; Lili Pang; Fengqin Hou
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

6.  Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.

Authors:  Tatsuo Kanda; Shin Yasui; Masato Nakamura; Shingo Nakamoto; Koji Takahashi; Shuang Wu; Reina Sasaki; Yuki Haga; Sadahisa Ogasawara; Tomoko Saito; Kazufumi Kobayashi; Soichiro Kiyono; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Hitoshi Maruyama; Fumio Imazeki; Mitsuhiko Moriyama; Naoya Kato
Journal:  Oncotarget       Date:  2018-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.